BSG and cancer: sCD147 detection in the serum or plasma obtained from several types of tumors, associated with tumor growth, metastasis formation, and chemoresistance, confers to CD147 its role as a clinical biomarker in several cancers, including hematological malignancies [36,37,38,39,40].